That is a very good point. From a rights perspective, it would have been better to negotiate global exclusivity. From a commercial perspective, already spent funds would have been better allocated to acquiring a controlling interest in Thermaquatica. If GPP survive the current leadership and poor execution issues, exclusivity will again become increasingly important for revenue scale.
Ann: Appendix 3B Placement, page-67
Add GNM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.855M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 674997 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 23334 | 1 |
View Market Depth
| Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
| GNM (ASX) Chart |
Day chart unavailable